Financial Statements — TS
Balance Sheet
(in billions USD)| Metric | FY
2025 | FY
2024 | FY
2023 | FY
2022 | FY
2021 | FY
2019 |
|---|
| Cash & Equivalents | 0.57 | 0.68 | 1.64 | 1.09 | 0.32 | 0.58 |
| Inventory | 3.60 | 3.71 | 3.92 | 3.99 | 2.67 | 1.64 |
| Total Current Assets | 9.07 | 9.24 | 10.50 | 8.47 | 4.98 | 4.29 |
| Goodwill | -- | -- | 1.10 | 1.09 | 1.09 | 1.09 |
| Total Non-current Assets | 11.00 | 11.21 | 10.58 | 9.08 | 9.47 | 9.43 |
| Total Assets | 20.07 | 20.45 | 21.08 | 17.55 | 14.45 | 13.72 |
| Total Current Liabilities | 2.35 | 2.64 | 2.90 | 2.79 | 1.56 | 1.17 |
| Total Non-current Liabilities | 0.90 | 1.00 | 1.15 | 0.73 | 0.78 | 1.10 |
| Total Liabilities | 3.24 | 3.64 | 4.05 | 3.52 | 2.34 | 2.27 |
| Total Stockholder Equity | 16.83 | 16.81 | 17.03 | 14.03 | 12.11 | 11.45 |
Income Statement
(in billions USD)| Metric | FY
2025 | FY
2024 | FY
2023 | FY
2022 | FY
2021 | FY
2019 |
|---|
| Total Revenue | 11.98 | 12.52 | 14.87 | 11.76 | 6.52 | 5.15 |
| Cost of Revenue* | 7.86 | 8.14 | 8.67 | 7.09 | 4.61 | 4.09 |
| Gross Profit | 4.12 | 4.39 | 6.20 | 4.67 | 1.91 | 1.06 |
| Research & Development | 0.06 | 0.07 | 0.06 | 0.05 | 0.05 | 0.04 |
| Selling, General & Admin | 1.83 | 1.90 | 1.92 | 1.63 | 1.21 | 1.12 |
| Total Operating Expenses* | 1.84 | 1.97 | 1.88 | 1.71 | 1.20 | 1.72 |
| Operating Income | 2.28 | 2.42 | 4.32 | 2.96 | 0.71 | (0.66) |
| Pretax Income | 2.47 | 2.56 | 4.63 | 3.17 | 1.24 | (0.62) |
| Tax Provision | 0.50 | 0.48 | 0.67 | 0.62 | 0.19 | 0.02 |
| Net Income | 1.97 | 2.08 | 3.96 | 2.55 | 1.05 | (0.64) |
* Derived from reported values
Cash Flow Statement
(in billions USD)| Metric | FY
2025 | FY
2024 | FY
2023 | FY
2022 | FY
2021 | FY
2019 |
|---|
| Operating Cash Flow | 2.60 | 2.87 | 4.40 | 1.17 | 0.12 | 1.52 |
| Investing Cash Flow | (0.19) | (1.40) | (2.69) | (0.16) | 0.27 | (2.09) |
| Financing Cash Flow | (2.48) | (2.40) | (1.13) | (0.18) | (0.65) | (0.38) |